Year |
Citation |
Score |
2016 |
Hung KM, Chen PC, Hsieh HC, Calkins MJ. Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders. Biochimica Et Biophysica Acta. PMID 27840304 DOI: 10.1016/J.Bbadis.2016.11.017 |
0.344 |
|
2016 |
Hung KM, Calkins MJ. Mitochondrial homeostatic disruptions are sensitive indicators of mitochondrial stress in neurons with defective mitochondrial DNA transactions. Mitochondrion. PMID 27581214 DOI: 10.1016/J.Mito.2016.08.015 |
0.38 |
|
2015 |
Fu MH, Li CL, Lin HL, Chen PC, Calkins MJ, Chang YF, Cheng PH, Yang SH. Stem cell transplantation therapy in Parkinson's disease. Springerplus. 4: 597. PMID 26543732 DOI: 10.1186/S40064-015-1400-1 |
0.351 |
|
2015 |
Lin CH, Li HY, Lee YC, Calkins MJ, Lee KH, Yang CN, Lu PJ. Landscape of Pin1 in the cell cycle. Experimental Biology and Medicine (Maywood, N.J.). 240: 403-8. PMID 25662955 DOI: 10.1177/1535370215570829 |
0.341 |
|
2012 |
Calkins MJ, Manczak M, Reddy PH. Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland). 5: 1103-19. PMID 23226091 DOI: 10.3390/ph5101103 |
0.33 |
|
2010 |
Calkins MJ, Townsend JA, Johnson DA, Johnson JA. Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription. Experimental Neurology. 224: 307-17. PMID 20406637 DOI: 10.1016/J.Expneurol.2010.04.008 |
0.546 |
|
2010 |
Calkins MJ, Vargas MR, Johnson DA, Johnson JA. Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition. Toxicological Sciences : An Official Journal of the Society of Toxicology. 115: 557-68. PMID 20211941 DOI: 10.1093/Toxsci/Kfq072 |
0.532 |
|
2009 |
Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, Williamson TP, Kraft AD, Lee JM, Li J, Johnson JA. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxidants & Redox Signaling. 11: 497-508. PMID 18717629 DOI: 10.1089/Ars.2008.2242 |
0.682 |
|
2008 |
Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, Chen PC. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Annals of the New York Academy of Sciences. 1147: 61-9. PMID 19076431 DOI: 10.1196/Annals.1427.036 |
0.721 |
|
2007 |
Li J, Calkins MJ, Johnson DA, Johnson JA. Role of Nrf2-dependent ARE-driven antioxidant pathway in neuroprotection. Methods in Molecular Biology (Clifton, N.J.). 399: 67-78. PMID 18309926 DOI: 10.1007/978-1-59745-504-6_6 |
0.618 |
|
2007 |
Johnson JA, Johnson DA, Lee JM, Li J, Kraft AD, Calkins MJ, Jakel RJ. The Nrf2-ARE pathway: A potential therapeutic target for neurodegenerative diseases International Congress Series. 1302: 143-153. DOI: 10.1016/j.ics.2006.10.026 |
0.726 |
|
2005 |
Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA. Nrf2, a multi-organ protector? Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1061-6. PMID 15985529 DOI: 10.1096/Fj.04-2591Hyp |
0.676 |
|
2005 |
Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proceedings of the National Academy of Sciences of the United States of America. 102: 244-9. PMID 15611470 DOI: 10.1073/Pnas.0408487101 |
0.757 |
|
2005 |
Li J, Johnson D, Calkins M, Wright L, Svendsen C, Johnson J. Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 83: 313-28. PMID 15525690 DOI: 10.1093/Toxsci/Kfi027 |
0.635 |
|
2003 |
Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. The Journal of Biological Chemistry. 278: 12029-38. PMID 12556532 DOI: 10.1074/Jbc.M211558200 |
0.631 |
|
Low-probability matches (unlikely to be authored by this person) |
2016 |
Chen YC, Li HY, Liang JL, Ger LP, Hsiao M, Calkins MJ, Cheng HC, Chuang JH, Lu PJ. CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient. Oncotarget. PMID 27447863 DOI: 10.18632/Oncotarget.10719 |
0.283 |
|
2016 |
Tsai SF, Chen PC, Calkins MJ, Wu SY, Kuo YM. Exercise Counteracts Aging-Related Memory Impairment: A Potential Role for the Astrocytic Metabolic Shuttle. Frontiers in Aging Neuroscience. 8: 57. PMID 27047373 DOI: 10.3389/Fnagi.2016.00057 |
0.27 |
|
2010 |
Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH, Park B, Reddy PH. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. Journal of Alzheimer's Disease : Jad. 20: S609-31. PMID 20463406 DOI: 10.3233/JAD-2010-100564 |
0.265 |
|
2011 |
Reddy PH, Reddy TP, Manczak M, Calkins MJ, Shirendeb U, Mao P. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Research Reviews. 67: 103-18. PMID 21145355 DOI: 10.1016/j.brainresrev.2010.11.004 |
0.258 |
|
2015 |
Hsu CY, Lin CH, Jan YH, Su CY, Yao YC, Cheng HC, Hsu TI, Wang PS, Su WP, Yang CJ, Huang MS, Calkins MJ, Hsiao M, Lu PJ. HIP1 is an Early-stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated EMT. American Journal of Respiratory and Critical Care Medicine. PMID 26595459 DOI: 10.1164/Rccm.201412-2226Oc |
0.25 |
|
2019 |
Lin CH, Li HY, Liu YP, Kuo PF, Wang WC, Lin FC, Chang WL, Sheu BS, Wang YC, Hung WC, Cheng HC, Yao YC, Calkins MJ, Hsiao M, Lu PJ. High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma. Therapeutic Advances in Medical Oncology. 11: 1758835919875324. PMID 31632466 DOI: 10.1177/1758835919875324 |
0.246 |
|
2012 |
Mao P, Manczak M, Calkins MJ, Truong Q, Reddy TP, Reddy AP, Shirendeb U, Lo HH, Rabinovitch PS, Reddy PH. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension. Human Molecular Genetics. 21: 2973-90. PMID 22492996 DOI: 10.1093/Hmg/Dds128 |
0.246 |
|
2011 |
Reddy TP, Manczak M, Calkins MJ, Mao P, Reddy AP, Shirendeb U, Park B, Reddy PH. Toxicity of neurons treated with herbicides and neuroprotection by mitochondria-targeted antioxidant SS31. International Journal of Environmental Research and Public Health. 8: 203-21. PMID 21318024 DOI: 10.3390/ijerph8010203 |
0.244 |
|
2017 |
Li HY, Liang JL, Kuo YL, Lee HH, Calkins MJ, Chang HT, Lin FC, Chen YC, Hsu TI, Hsiao M, Ger LP, Lu PJ. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer. Breast Cancer Research : Bcr. 19: 133. PMID 29258605 DOI: 10.1186/S13058-017-0918-2 |
0.238 |
|
2011 |
Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, Reddy PH. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Human Molecular Genetics. 20: 1438-55. PMID 21257639 DOI: 10.1093/hmg/ddr024 |
0.229 |
|
2011 |
Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Human Molecular Genetics. 20: 4515-29. PMID 21873260 DOI: 10.1093/hmg/ddr381 |
0.224 |
|
2016 |
Lin CH, Tsai CH, Yeh CT, Liang JL, Hung WC, Lin FC, Chang WL, Li HY, Yao YC, Hsu TI, Lee YC, Wang YC, Sheu BS, Lai WW, Calkins MJ, et al. MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma. Oncotarget. PMID 27203740 DOI: 10.18632/Oncotarget.9444 |
0.223 |
|
2011 |
Manczak M, Calkins MJ, Reddy PH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Human Molecular Genetics. 20: 2495-509. PMID 21459773 DOI: 10.1093/hmg/ddr139 |
0.218 |
|
2012 |
Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. Human Molecular Genetics. 21: 406-20. PMID 21997870 DOI: 10.1093/Hmg/Ddr475 |
0.212 |
|
2012 |
Reddy PH, Tripathi R, Troung Q, Tirumala K, Reddy TP, Anekonda V, Shirendeb UP, Calkins MJ, Reddy AP, Mao P, Manczak M. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochimica Et Biophysica Acta. 1822: 639-49. PMID 22037588 DOI: 10.1016/j.bbadis.2011.10.011 |
0.204 |
|
2020 |
Bhupana JN, Huang BT, Liou GG, Calkins MJ, Lin-Chao S. Gas7 knockout affects PINK1 expression and mitochondrial dynamics in mouse cortical neurons. Faseb Bioadvances. 2: 166-181. PMID 32161906 DOI: 10.1096/fba.2019-00091 |
0.197 |
|
2022 |
Lin SC, Yao CY, Hsu CA, Lin CT, Calkins MJ, Kuo YY, Tang JL, Tien HF, Wu SJ. Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis. Annals of Hematology. PMID 36040481 DOI: 10.1007/s00277-022-04961-1 |
0.19 |
|
2016 |
Calkins MJ, Vartanian V, Owen N, Kirkali G, Jaruga P, Dizdaroglu M, McCullough AK, Lloyd RS. Enhanced sensitivity of Neil1(-/-) mice to chronic UVB exposure. Dna Repair. PMID 27818081 DOI: 10.1016/j.dnarep.2016.10.010 |
0.186 |
|
2011 |
Calkins MJ, Reddy PH. Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage. Biochimica Et Biophysica Acta. 1812: 1182-9. PMID 21549836 DOI: 10.1016/j.bbadis.2011.04.006 |
0.185 |
|
2018 |
Sha Y, Vartanian V, Owen N, Mengden Koon SJ, Calkins MJ, Thompson CS, Mirafzali Z, Mir S, Goldsmith LE, He H, Luo C, Brown SM, Doetsch PW, Kaempf A, Lim JY, et al. Modulation of UVB-induced Carcinogenesis by Activation of Alternative DNA Repair Pathways. Scientific Reports. 8: 705. PMID 29335541 DOI: 10.1038/S41598-017-17940-8 |
0.17 |
|
2010 |
Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U. Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline. Journal of Alzheimer's Disease : Jad. 20: S499-512. PMID 20413847 DOI: 10.3233/JAD-2010-100504 |
0.164 |
|
2011 |
Calkins MJ, Reddy PH. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons. Biochimica Et Biophysica Acta. 1812: 507-13. PMID 21241801 DOI: 10.1016/j.bbadis.2011.01.007 |
0.162 |
|
2015 |
Fu MH, Li CL, Lin HL, Chen PC, Calkins MJ, Chang YF, Cheng PH, Yang SH. Stem cell transplantation therapy in Parkinson’s disease Springerplus. 4. DOI: 10.1186/s40064-015-1400-1 |
0.146 |
|
2013 |
Jacobs AC, Calkins MJ, Jadhav A, Dorjsuren D, Maloney D, Simeonov A, Jaruga P, Dizdaroglu M, McCullough AK, Lloyd RS. Inhibition of DNA glycosylases via small molecule purine analogs. Plos One. 8: e81667. PMID 24349107 DOI: 10.1371/journal.pone.0081667 |
0.144 |
|
2020 |
Irham LM, Chou WH, Calkins MJ, Adikusuma W, Hsieh SL, Chang WC. Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents. Biochemical and Biophysical Research Communications. 529: 263-269. PMID 32703421 DOI: 10.1016/j.bbrc.2020.05.179 |
0.125 |
|
2020 |
Kuo YY, Lin YC, Calkins MJ, Chen PC. Endonuclease VIII-like 1 deficiency impairs survival of newly generated hippocampal neurons and memory performance in young-adult male mice. Life Sciences. 117755. PMID 32437792 DOI: 10.1016/j.lfs.2020.117755 |
0.123 |
|
2016 |
Dizdaroglu M, Jacobs AC, Calkins MJ, Jadhav A, Dorjsuren D, Maloney D, Simeonov A, Donley N, Jaruga P, Coskun E, Mccullough AK, Lloyd S. Inhibition of DNA glycosylases in development of cancer therapeutics Toxicology Letters. 258: S19-S20. DOI: 10.1016/j.toxlet.2016.06.1184 |
0.081 |
|
Hide low-probability matches. |